Rebecca Byam, CFO of HCW Biologics HCWB, has filed 18 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $20.1K. The latest trade was on 05/22.

RB

RB

Rebecca Byam

CFO

Company

HCW Biologics HCWB

First filing

23/05/24

Trades

23 trades

Buys / sales

18 / 0

12-month net buying

$20.1K

Last trade

05/22

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
HCW BiologicsHCWB	Open-market buy	05/22	05/27	14,235 sh	$1.41	$20,071.35	+33.1%
HCW BiologicsHCWB	Open-market buy	25/05/08	25/05/09	8,462 sh	$26.00	$220,012	+24.5%
HCW BiologicsHCWB	Open-market buy	23/09/13	23/09/15	5,000 sh	$2.10	$10,500	+0.9%
HCW BiologicsHCWB	Open-market buy	23/09/11–23/09/12	23/09/13	10,000 sh2 trades	$2.07avg.	$20,700	+1.8%
HCW BiologicsHCWB	Open-market buy	23/09/07–23/09/08	23/09/08	10,000 sh2 trades	$1.99avg.	$19,850	+1.8%
HCW BiologicsHCWB	Open-market buy	23/09/06	23/09/07	5,000 sh	$1.95	$9,750	+0.9%
HCW BiologicsHCWB	Open-market buy	23/06/09	23/06/09	20,000 sh	$2.06	$41,200	+3.8%
HCW BiologicsHCWB	Open-market buy	23/06/07–23/06/08	23/06/08	24,696 sh2 trades	$2.06avg.	$50,978.16	+4.9%
HCW BiologicsHCWB	Open-market buy	23/06/05–23/06/06	23/06/07	39,062 sh2 trades	$1.74avg.	$68,092.84	+8.5%
HCW BiologicsHCWB	Open-market buy	23/05/25–23/05/26	23/05/31	40,000 sh2 trades	$1.64avg.	$65,600	+9.5%
HCW BiologicsHCWB	Open-market buy	23/05/22–23/05/24	23/05/24	58,486 sh3 trades	$1.56avg.	$91,285.02	+16.2%